Scleromyxedema as a Systemic Disease of Glycosaminoglycan Accumulation

Arkhiv Patologii - Russian Federation
doi 10.17116/patol201880353-58
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Media Sphere Publishing Group

Related search

Depression as a Systemic Disease

Personalized Medicine in Psychiatry
2017English

Coexistence of Anemia and COPD as a Systemic Disease

Solunum
2012English

Systemic JIA as an Autoinflammatory Disease

Inflammation and Regeneration
AllergyImmunology
2011English

Accumulation of Health Disorders as a Systemic Measure of Aging: Findings From the NLTCS Data

Mechanisms of Ageing and Development
AgingDevelopmental Biology
2006English

Psoriasis, a Systemic Disease?

Turk Dermatoloji Dergisi
Dermatology
2012English

Scleromyxedema Problem in Odontological Practice

International Journal of Innovation Education and Research
2019English

Arndt-Gottron Scleromyxedema: Case Report

Romanian Journal of Clinical and Experimental Dermatology
2018English

Reply To: Is Low Disease Activity Good Enough as a Target in Systemic

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Is Low Disease Activity Good Enough as a Target in Systemic Lupus Erythematosus?

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy